Characterization of serotonin binding sites on human platelets

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• The serotonin-2 (S-2) receptor is a key neurotransmitter receptor in the human brain.
• Investigating peripheral markers for central nervous system receptors can provide valuable insights into receptor function and related conditions.

Purpose of the Study:

• To identify and characterize specific serotonin binding sites on intact human platelets.
• To evaluate the potential of platelet receptors as a model for studying S-2 receptor function in humans.

Main Methods:

• Radioligand binding assays were performed using 3H-spiroperidol and 3H-serotonin on intact human platelets.
• Binding affinities (KD) and maximum binding capacities (Bmax) were determined.

Main Results:

• A high-affinity, saturable 3H-spiroperidol binding site, comparable to the brain's S-2 receptor, was identified on human platelets (KD = 2.7 ± 0.3 nM, Bmax = 1.4 ± 0.2 pmoles/10^8 platelets).
• A 3H-serotonin binding site, likely representing the serotonin uptake site (KD = 42 ± 8 nM), was also observed.
• No platelet binding site consistent with the brain's serotonin-1 (S-1) receptor was detected.

Conclusions:

• Intact human platelets possess a specific 3H-spiroperidol binding site analogous to the S-2 receptor.
• Platelet 3H-spiroperidol binding assays represent a practical model for investigating S-2 receptor activity in humans.
• This model may be useful for exploring the influence of age, hormones, drugs, and diseases on S-2 receptor function.